Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Recurrent Respiratory Tract Infections · Actinic Keratosis on the Face or Scalp

ALMIRALL S.P.A

Almirall, S.A.

ALMIRALL S.P.A patent portfolio — 22 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona HQ
2 Employees
NMPA registrant Type
Company details
Status
Public
HQ
VIA MESSINA 38, MILANO, Mi 20154, IT, Barcelona
Employees
2
Programs
0
Drugs
15
Patents
22
Official website ↗ Drug pipeline Patents News & analysis
Intelligence · Patents

ALMIRALL S.P.A patents

22 pharmaceutical patents indexed for ALMIRALL S.P.A. 0 expire within 24 months.

ALMIRALL S.P.A has 22 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

22 patents

Patent portfolio

  1. US 12383503

    Adagrasib solid pharmaceutical compositions

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12336995

    Combination therapies

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12281113

    Crystalline forms of a KRas G12C inhibitor

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11965040

    Modulation of complement activity

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11752190

    Modulators of complement activity

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11535650

    Modulation of complement activity

    Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11273132

    Topical dapsone and dapsone/adapalene compositions and methods for use thereof

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11014965

    Modulation of complement activity

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11000517

    Dosage and formulation

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10835574

    Modulators of complement activity

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10689377

    KRas G12C inhibitors

    Expires Mon Jun 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10562934

    Modulation of complement activity

    Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10548875

    Glycopyrrolate salts

    Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10543192

    Glycopyrrolate salts

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10435438

    Modulation of complement activity

    Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10208089

    Modulation of complement activity

    Expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10106579

    Modulation of complement activity

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10085974

    Dosage and formulation

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10004717

    Glycopyrrolate salts

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9259414

    Glycopyrrolate salts

    Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8802644

    Lipid formulation

    Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8642076

    Lipid containing formulations

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ALMIRALL S.P.A have?

22 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ALMIRALL S.P.A patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.